WHO ICTRP trial
Comparison of Metformin therapy with Placebo therapy on progression of disease…
CTRI/2024/06/069541 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/06/069541 |
|---|---|
| Public title | Comparison of Metformin therapy with Placebo therapy on progression of disease in the patients with Autosomal Dominant Polycystic Kidney Disease. |
| Scientific title | Effect of Metformin therapy on progression of Autosomal Dominant Polycystic Kidney Disease: an open label 2: 1 randomized controlled trial - NIL |
| Primary sponsor | IPGMER and SSKM hospital |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: Q612- Polycystic kidney, adult type |
| Interventions | Intervention1: Metformin : tablet Metformin at 1gm twice a day par orally for 12 months Control Intervention1: Placebo: Similar looking Vitamin B tablets with Vitamin B12 750 microgram twice a day par orally for 12 months |
| Registration date | Jun 26, 2024 |
| Target size | 108 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: